Kura Oncology Ownership | Who Owns Kura Oncology?
Kura Oncology Ownership Summary
Kura Oncology is owned by 33.03% institutional investors, 1.19% insiders, and 65.78% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 9.12% of KURA shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 3.41% of its assets in Kura Oncology shares.
KURA Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Kura Oncology | 33.03% | 1.19% | 65.78% |
| Sector | Healthcare Stocks | 57.39% | 9.93% | 32.68% |
| Industry | Biotech Stocks | 68.48% | 9.65% | 21.87% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Blackrock funding, inc. /de | 7.93M | 9.12% | $69.11M |
| Blackrock | 6.97M | 8.30% | $143.43M |
| Armistice capital | 5.80M | 6.67% | $50.52M |
| Suvretta capital management | 5.08M | 5.84% | $44.22M |
| Vanguard group | 4.82M | 5.54% | $41.97M |
| Ra capital management | 4.45M | 5.12% | $38.77M |
| Ecor1 capital | 3.56M | 4.09% | $30.98M |
| State street | 2.88M | 3.44% | $59.39M |
| Bvf inc/il | 2.57M | 2.95% | $22.36M |
| Millennium management | 2.37M | 2.72% | $20.62M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Foresite capital management iv | 1.73M | 13.82% | $15.04M |
| Alethea capital management | 558.44K | 4.16% | $4.86M |
| Prosight management, lp | 629.90K | 3.88% | $12.97M |
| Suvretta capital management | 5.08M | 1.51% | $44.22M |
| 1492 capital management | 342.60K | 1.42% | $2.98M |
| Tcg crossover management | 1.42M | 1.21% | $12.40M |
| Superstring capital management lp | 157.96K | 1.19% | $1.38M |
| Ecor1 capital | 3.56M | 1.17% | $30.98M |
| Velan capital investment management lp | 150.00K | 1.13% | $1.31M |
| Propel bio management | 130.00K | 1.12% | $1.13M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Ra capital management | 4.45M | 0.52% | 4.45M |
| Armistice capital | 5.80M | 0.69% | 3.14M |
| Millennium management | 2.37M | 0.01% | 1.52M |
| Qube research | 1.12M | 0.01% | 1.01M |
| Marshall wace, llp | 948.90K | 0.01% | 948.90K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Deerfield management company, l.p. (series c) | - | - | -5.41M |
| Paradigm biocapital advisors lp | - | - | -4.33M |
| Suvretta capital management | 5.08M | 1.51% | -2.58M |
| Holocene advisors, lp | 226.90K | 0.01% | -2.46M |
| Ecor1 capital | 3.56M | 1.17% | -2.25M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Ra capital management | 4.45M | 0.52% | 4.45M | $38.77M |
| Bnp paribas asset management | 694.39K | 0.01% | 694.39K | $6.05M |
| Voss capital | 275.00K | 0.18% | 275.00K | $2.40M |
| Velan capital investment management lp | 150.00K | 1.13% | 150.00K | $1.31M |
| Wealthfront advisers | 147.94K | 0.02% | 147.94K | $6.07M |
Sold Out
| Holder | Change |
|---|---|
| National bank of canada /fi/ | -1.00 |
| Nelson, van denburg & campbell wealth management group | -14.00 |
| Quantbot technologies lp | -14.00 |
| Massmutual trust co fsb/adv | -19.00 |
| Srs capital advisors | -26.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | 104 | -43.48% | 28,722,448 | -65.13% | 33 | 0.37% | 68 | -17.07% | 14 | -75.00% |
| Sep 30, 2024 | 183 | 2.23% | 82,304,529 | 2.31% | 94 | 1.03% | 82 | -2.38% | 56 | -9.68% |
| Jun 30, 2024 | 179 | 4.68% | 80,450,005 | -0.33% | 95 | 1.04% | 84 | -11.58% | 62 | 31.91% |
| Mar 31, 2024 | 171 | 20.42% | 80,714,791 | 2.51% | 96 | 0.93% | 95 | 33.80% | 47 | 9.30% |
| Dec 31, 2023 | 142 | 5.97% | 78,740,296 | 4.56% | 101 | 1.07% | 71 | -4.05% | 43 | 30.30% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 2.75M | 3.41% | - |
| Vanguard US Total Market Shares ETF | 2.17M | 2.68% | 3.54K |
| iShares Russell 2000 ETF | 1.95M | 2.41% | -16.89K |
| SPDR® S&P Biotech ETF | 1.61M | 1.99% | -17.20K |
| Vanguard Institutional Extnd Mkt Idx Tr | 1.27M | 1.57% | 40.02K |
| HBM Healthcare Investments AG Ord | 1.21M | 1.56% | 710.00K |
| Fidelity Small Cap Index | 709.18K | 0.88% | -13.28K |
| iShares Russell 2000 Growth ETF | 655.84K | 0.81% | -3.12K |
| Franklin US Small Cap Growth Equity | 621.52K | 0.80% | -57.60K |
| Franklin Biotechnology Discv A(acc)USD | 533.90K | 0.66% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Mar 21, 2025 | Hasnain Faheem | - | Sell | $181.46K |
| Jan 28, 2025 | DOYLE THOMAS JAMES | SVP, Finance & Accounting | Sell | $6.98K |
| Jan 28, 2025 | DOYLE THOMAS JAMES | SVP, Finance & Accounting | Sell | $17.64K |
| Jan 28, 2025 | DOYLE THOMAS JAMES | SVP, Finance & Accounting | Sell | $5.50K |
| Jan 28, 2025 | DOYLE THOMAS JAMES | SVP, Finance & Accounting | Sell | $8.83K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q1 | - | 14 |
| 2024 Q4 | - | 1 |
| 2024 Q3 | - | - |
| 2024 Q2 | - | 1 |
| 2024 Q1 | - | 9 |
KURA Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools